Your browser is no longer supported. Please, upgrade your browser.
Settings
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E28.19 EPS (ttm)15.96 Insider Own0.10% Shs Outstand396.00M Perf Week-6.01%
Market Cap178.93B Forward P/E22.36 EPS next Y20.13 Insider Trans-15.07% Shs Float395.52M Perf Month-6.72%
Income6.38B PEG6.90 EPS next Q6.56 Inst Own90.60% Short Float0.72% Perf Quarter2.39%
Sales32.22B P/S5.55 EPS this Y73.80% Inst Trans-0.88% Short Ratio1.67 Perf Half Y5.74%
Book/sh87.14 P/B5.17 EPS next Y-8.50% ROA10.10% Target Price567.06 Perf Year51.50%
Cash/sh26.04 P/C17.28 EPS next 5Y4.09% ROE20.40% 52W Range250.21 - 532.57 Perf YTD-3.37%
Dividend1.04 P/FCF27.62 EPS past 5Y26.50% ROI12.30% 52W High-15.49% Beta0.79
Dividend %0.23% Quick Ratio1.70 Sales past 5Y13.70% Gross Margin50.10% 52W Low79.88% ATR12.97
Employees80000 Current Ratio2.10 Sales Q/Q54.50% Oper. Margin24.20% RSI (14)32.53 Volatility2.56% 2.65%
OptionableYes Debt/Eq0.63 EPS Q/Q151.80% Profit Margin19.80% Rel Volume1.27 Prev Close451.47
ShortableYes LT Debt/Eq0.55 EarningsFeb 01 BMO Payout5.30% Avg Volume1.70M Price450.08
Recom1.80 SMA20-8.05% SMA50-7.52% SMA2003.63% Volume2,153,076 Change-0.31%
Jan-08-21Upgrade Credit Suisse Neutral → Outperform $490 → $556
Dec-16-20Downgrade Citigroup Buy → Neutral $550 → $500
Dec-02-20Initiated Goldman Buy $570
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $550
Sep-30-20Initiated Atlantic Equities Overweight $494
Sep-14-20Initiated Morgan Stanley Overweight $485
Aug-20-20Resumed JP Morgan Overweight $460
Jul-15-20Upgrade Cleveland Research Neutral → Buy
Jul-07-20Reiterated Needham Buy $383 → $415
Apr-23-20Reiterated Needham Buy $341 → $383
Jan-31-20Reiterated Needham Buy $331 → $341
Jan-22-20Initiated Credit Suisse Neutral $341
Jan-08-20Initiated Wells Fargo Equal Weight $350
Jan-07-20Initiated Citigroup Buy $380
Nov-15-19Initiated Stifel Buy
Jul-25-19Reiterated Needham Buy $315 → $321
Jul-16-19Downgrade Needham Strong Buy → Buy $315
May-30-19Initiated Wolfe Research Outperform
May-23-19Reiterated Needham Strong Buy $313 → $315
Apr-22-19Reiterated Needham Strong Buy $271 → $312
Feb-27-21 07:30AM  
Feb-26-21 08:00AM  
Feb-24-21 04:47PM  
Feb-23-21 05:00PM  
11:38AM  
Feb-17-21 08:00AM  
Feb-14-21 12:39PM  
Feb-12-21 08:30AM  
05:22AM  
Feb-11-21 08:49PM  
08:00AM  
Feb-10-21 11:26AM  
Feb-05-21 06:30AM  
Feb-03-21 10:42AM  
Feb-02-21 01:16PM  
10:27AM  
09:41AM  
09:39AM  
08:35AM  
03:08AM  
Feb-01-21 02:00PM  
12:00PM  
11:34AM  
11:28AM  
07:30AM  
07:19AM  
06:30AM  
06:17AM  
06:00AM  
05:17AM  
03:43AM  
Jan-30-21 08:00AM  
Jan-29-21 10:08AM  
08:45AM  
08:00AM  
Jan-28-21 10:26AM  
Jan-27-21 06:00AM  
Jan-25-21 05:45PM  
11:25AM  
Jan-22-21 03:45PM  
Jan-19-21 04:02PM  
09:07AM  
08:22AM  
08:00AM  
Jan-18-21 08:46AM  
Jan-16-21 08:00AM  
Jan-15-21 05:50PM  
06:30AM  
Jan-14-21 12:28PM  
09:06AM  
Jan-13-21 04:26PM  
04:40AM  
Jan-12-21 10:14AM  
Jan-08-21 01:05PM  
12:48PM  
Jan-06-21 05:45PM  
08:00AM  
08:00AM  
Jan-05-21 04:01PM  
12:10PM  
06:57AM  
Jan-04-21 12:00AM  
Dec-31-20 05:45PM  
Dec-30-20 04:05PM  
Dec-23-20 05:45PM  
08:00AM  
Dec-22-20 10:00AM  
Dec-21-20 11:38AM  
09:33AM  
08:50AM  
08:48AM  
Dec-18-20 08:57AM  
08:00AM  
Dec-17-20 05:45PM  
04:24PM  
06:09AM  
Dec-16-20 02:01PM  
11:57AM  
09:07AM  
08:00AM  
Dec-15-20 12:00PM  
09:49AM  
09:47AM  
Dec-14-20 11:46AM  
10:00AM  
06:08AM  
Dec-11-20 05:45PM  
08:20AM  
Dec-10-20 11:34AM  
08:51AM  
Dec-09-20 11:39AM  
11:38AM  
09:30AM  
09:27AM  
08:18AM  
Dec-08-20 12:57PM  
12:45PM  
10:18AM  
10:12AM  
10:00AM  
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; cancer diagnosis and medical research products; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics and chemicals; and pharma services. It has collaboration with WuXi Diagnostics and Mayo Clinic to develop antibodies tests; a strategic collaboration with Schrodinger, Inc.; an agreement with Daiichi Sankyo; collaboration with Northeastern University; and partnership with Boys & Girls Clubs of America. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lagarde MichelExecutive Vice PresidentFeb 12Sale507.797,2903,701,78915,775Feb 17 04:01 PM
Stevenson MarkExecutive Vice President & COODec 07Option Exercise129.7723,8253,091,77067,717Dec 08 04:31 PM
Stevenson MarkExecutive Vice President & COODec 07Sale473.8414,1336,696,78153,584Dec 08 04:31 PM
Stevenson MarkExecutive Vice President & COODec 04Option Exercise129.7723,8253,091,77058,005Dec 08 04:31 PM
Stevenson MarkExecutive Vice President & COODec 04Sale476.4614,1136,724,28043,892Dec 08 04:31 PM
CASPER MARC NChairman & CEONov 02Sale484.0915,0007,261,35054,330Nov 04 04:09 PM
CASPER MARC NChairman & CEOOct 27Sale487.8310,0004,878,287211,594Oct 28 05:18 PM
CASPER MARC NChairman & CEOOct 26Sale479.9410,0004,799,386221,594Oct 28 05:18 PM
Stevenson MarkExecutive Vice President & COOAug 25Option Exercise131.0722,0002,883,54056,561Aug 27 04:22 PM
Stevenson MarkExecutive Vice President & COOAug 25Sale420.1622,0009,243,52034,561Aug 27 04:22 PM
Stevenson MarkExecutive Vice President & COOAug 24Option Exercise131.0722,0002,883,54070,621Aug 25 04:04 PM
Stevenson MarkExecutive Vice President & COOAug 24Sale429.5522,0009,450,10048,621Aug 25 04:04 PM
HORNSTRA PETER EVP & Chief Accounting OfficerAug 18Option Exercise136.503,337455,51219,862Aug 19 04:20 PM
HORNSTRA PETER EVP & Chief Accounting OfficerAug 18Sale418.823,3371,397,61918,212Aug 19 04:20 PM
CASPER MARC NChairman & CEOJul 31Option Exercise131.0720,0002,621,400260,446Aug 03 04:32 PM
CASPER MARC NChairman & CEOJul 31Sale409.0220,0008,180,400240,446Aug 03 04:32 PM
CASPER MARC NChairman & CEOJul 30Option Exercise131.0720,0002,621,400260,446Aug 03 04:32 PM
CASPER MARC NChairman & CEOJul 30Sale405.3120,0008,106,200240,446Aug 03 04:32 PM
CASPER MARC NChairman & CEOJul 29Option Exercise131.0720,0002,621,400260,446Jul 30 07:49 PM
Williamson StephenSr. VP and CFOJul 29Option Exercise131.0719,8002,595,18657,789Jul 31 04:03 PM
Williamson StephenSr. VP and CFOJul 29Sale410.8319,8008,134,47137,989Jul 31 04:03 PM
CASPER MARC NChairman & CEOJul 29Sale411.0520,0008,221,015240,446Jul 30 07:49 PM
CASPER MARC NChairman & CEOJul 28Option Exercise131.0720,0002,621,400260,446Jul 30 07:49 PM
CASPER MARC NChairman & CEOJul 28Sale411.6220,0008,232,400240,446Jul 30 07:49 PM
CASPER MARC NChairman & CEOJul 27Option Exercise131.0720,0002,621,400260,446Jul 28 04:13 PM
Jafry Syed A.Sr. Vice PresidentJul 27Option Exercise181.0820,5133,714,47927,219Jul 29 04:09 PM
Jafry Syed A.Sr. Vice PresidentJul 27Sale414.9420,5138,511,64621,019Jul 29 04:09 PM
CASPER MARC NChairman & CEOJul 27Sale404.4020,0008,088,000240,446Jul 28 04:13 PM
Stevenson MarkExecutive Vice President & COOJul 24Option Exercise124.2825,0003,107,00073,621Jul 28 04:06 PM
CASPER MARC NChairman & CEOJul 24Option Exercise131.0720,0002,621,400260,446Jul 28 04:13 PM
CASPER MARC NChairman & CEOJul 24Sale403.3720,0008,067,400240,446Jul 28 04:13 PM
Stevenson MarkExecutive Vice President & COOJul 24Sale404.5825,00010,114,46548,621Jul 28 04:06 PM
MANZI JIM PDirectorJul 24Sale402.383,2181,294,86518,986Jul 28 04:01 PM
CASPER MARC NChairman & CEOJun 02Option Exercise124.2814,7951,838,723289,741Jun 04 04:37 PM
CASPER MARC NChairman & CEOJun 02Sale349.5514,7955,171,606274,946Jun 04 04:37 PM
CASPER MARC NChairman & CEOJun 01Option Exercise124.2820,0002,485,600294,946Jun 02 04:19 PM
Williamson StephenSr. VP and CFOJun 01Sale348.002,500870,00037,989Jun 02 04:21 PM
CASPER MARC NChairman & CEOJun 01Sale349.8920,0006,997,718274,946Jun 02 04:19 PM
CASPER MARC NChairman & CEOMay 29Option Exercise124.2820,0002,485,600294,946Jun 02 04:19 PM
CASPER MARC NChairman & CEOMay 29Sale349.2620,0006,985,200274,946Jun 02 04:19 PM
Stevenson MarkExecutive Vice President & COOMay 18Option Exercise124.2825,0003,107,00073,621May 20 04:47 PM
CASPER MARC NChairman & CEOMay 18Option Exercise124.2816,7052,076,097291,651May 20 05:07 PM
Stevenson MarkExecutive Vice President & COOMay 18Sale348.7825,0008,719,57548,621May 20 04:47 PM
CASPER MARC NChairman & CEOMay 18Sale349.4416,7055,837,472274,946May 20 05:07 PM
CASPER MARC NChairman & CEOApr 28Option Exercise124.2830,0003,728,400304,946Apr 29 04:22 PM
CASPER MARC NChairman & CEOApr 28Sale333.0230,0009,990,609274,946Apr 29 04:22 PM
Stevenson MarkExecutive Vice President & COOApr 24Option Exercise124.2825,0003,107,00073,538Apr 27 06:55 PM
Stevenson MarkExecutive Vice President & COOApr 24Sale328.0325,0008,200,65548,538Apr 27 06:55 PM
Williamson StephenSr. VP and CFOMar 04Option Exercise124.288,7001,081,23649,189Mar 05 04:34 PM
Stevenson MarkExecutive Vice President & COOMar 04Option Exercise124.2825,0003,107,00073,538Mar 05 04:59 PM
Stevenson MarkExecutive Vice President & COOMar 04Sale324.2825,0008,107,00048,538Mar 05 04:59 PM
Williamson StephenSr. VP and CFOMar 04Sale318.548,7002,771,29840,489Mar 05 04:34 PM
Lagarde MichelExecutive Vice PresidentMar 04Sale318.5412,0003,822,48026,385Mar 05 04:28 PM
Lagarde MichelExecutive Vice PresidentMar 03Sale319.8112,0003,837,72038,385Mar 05 04:28 PM
Williamson StephenSr. VP and CFOMar 02Sale291.032,500727,57540,489Mar 04 04:00 PM